UK markets closed

Bunge Limited (BG)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
93.93+0.39 (+0.42%)
At close: 04:00PM EDT
93.78 -0.15 (-0.16%)
After hours: 07:37PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.81B
Enterprise value 18.21B
Trailing P/E 8.76
Forward P/E 7.79
PEG ratio (5-yr expected) 1.71
Price/sales (ttm)0.21
Price/book (mrq)1.50
Enterprise value/revenue 0.27
Enterprise value/EBITDA 6.33

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-20.19%
S&P500 52-week change 3-13.08%
52-week high 3128.40
52-week low 380.41
50-day moving average 397.51
200-day moving average 395.73

Share statistics

Avg vol (3-month) 31.87M
Avg vol (10-day) 36.25M
Shares outstanding 5149.93M
Implied shares outstanding 6N/A
Float 8148.62M
% held by insiders 10.75%
% held by institutions 188.26%
Shares short (27 Feb 2023) 42.79M
Short ratio (27 Feb 2023) 42.53
Short % of float (27 Feb 2023) 42.14%
Short % of shares outstanding (27 Feb 2023) 41.86%
Shares short (prior month 30 Jan 2023) 42.83M

Dividends & splits

Forward annual dividend rate 42.5
Forward annual dividend yield 42.63%
Trailing annual dividend rate 32.40
Trailing annual dividend yield 32.57%
5-year average dividend yield 43.07
Payout ratio 421.88%
Dividend date 301 Jun 2023
Ex-dividend date 417 May 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 2.39%
Operating margin (ttm)3.87%

Management effectiveness

Return on assets (ttm)6.72%
Return on equity (ttm)18.47%

Income statement

Revenue (ttm)67.23B
Revenue per share (ttm)452.10
Quarterly revenue growth (yoy)-0.10%
Gross profit (ttm)3.92B
Net income avi to common (ttm)1.61B
Diluted EPS (ttm)10.35
Quarterly earnings growth (yoy)45.50%

Balance sheet

Total cash (mrq)1.22B
Total cash per share (mrq)8.16
Total debt (mrq)5.62B
Total debt/equity (mrq)56.46
Current ratio (mrq)1.75
Book value per share (mrq)61.53

Cash flow statement

Operating cash flow (ttm)-5.55B
Levered free cash flow (ttm)782M